<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">34912599</PMID><DateRevised><Year>2024</Year><Month>08</Month><Day>19</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2168-8184</ISSN><JournalIssue CitedMedium="Print"><Volume>13</Volume><Issue>11</Issue><PubDate><Year>2021</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Cureus</Title><ISOAbbreviation>Cureus</ISOAbbreviation></Journal><ArticleTitle>Myopericarditis as a Manifestation of Long COVID Syndrome.</ArticleTitle><Pagination><StartPage>e19449</StartPage><MedlinePgn>e19449</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e19449</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.7759/cureus.19449</ELocationID><Abstract><AbstractText>The main presentation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is respiratory. However, there are extrapulmonary manifestations such as myocardial and pericardial injury. The term long COVID syndrome describes the persistence of symptoms in patients who have recovered from the infection. A 31-year-old man presented with mild coronavirus disease 2019 (COVID-19) symptoms for three days. Two weeks later, he developed chest pain, pericardial rub, and pericardial effusion; he underwent echocardiography showing pericarditis and an MRI which revealed inferoseptal hypokinesia and mild global myocardial hyperintensity, cardiac scintigraphy with Ga-67, and an inflammatory process in the myocardium. He was treated with methylprednisolone pulse (1g IV/day) and tapering prednisone (5 mg/day), with gradual evolution of symptoms for one year. In conclusion, this is a patient without comorbidities with clinical, laboratory, and imaging diagnosis of myopericarditis as a manifestation of long COVID syndrome.</AbstractText><CopyrightInformation>Copyright &#xa9; 2021, Vera-Lastra et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Vera-Lastra</LastName><ForeName>Olga</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Internal Medicine, Hospital de Especialidades Dr. Antonio Fraga Mouret, Instituto Mexicano del Seguro Social, Mexico City, MEX.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Post-graduate Studies, Faculty of Medicine, Universidad Nacional Aut&#xf3;noma de M&#xe9;xico, Mexico City, MEX.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lucas-Hern&#xe1;ndez</LastName><ForeName>Abihai</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Internal Medicine, Hospital de Especialidades Dr. Antonio Fraga Mouret, Instituto Mexicano del Seguro Social, Mexico City, MEX.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Post-graduate Studies, Faculty of Medicine, Universidad Nacional Aut&#xf3;noma de M&#xe9;xico, Mexico City, MEX.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ruiz-Montiel</LastName><ForeName>Jose E</ForeName><Initials>JE</Initials><AffiliationInfo><Affiliation>Internal Medicine, Hospital de Especialidades Dr. Antonio Fraga Mouret, Instituto Mexicano del Seguro Social, Mexico City, MEX.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Post-graduate Studies, Faculty of Medicine, Universidad Nacional Aut&#xf3;noma de M&#xe9;xico, Mexico City, MEX.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gonzalez-Rodriguez</LastName><ForeName>Viviana R</ForeName><Initials>VR</Initials><AffiliationInfo><Affiliation>Internal Medicine, Hospital de Especialidades Dr. Antonio Fraga Mouret, Instituto Mexicano del Seguro Social, Mexico City, MEX.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Multidisciplinary Academic Division of Comalcalco, Universidad Ju&#xe1;rez Aut&#xf3;noma de Tabasco, Tabasco, MEX.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pineda-Galindo</LastName><ForeName>Luis F</ForeName><Initials>LF</Initials><AffiliationInfo><Affiliation>Internal Medicine, Hospital de Especialidades Dr. Antonio Fraga Mouret, Instituto Mexicano del Seguro Social, Mexico City, MEX.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Post-graduate Studies, Faculty of Medicine, Universidad Nacional Aut&#xf3;noma de M&#xe9;xico, Mexico City, MEX.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>11</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cureus</MedlineTA><NlmUniqueID>101596737</NlmUniqueID><ISSNLinking>2168-8184</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">covid-19</Keyword><Keyword MajorTopicYN="N">diagnosis</Keyword><Keyword MajorTopicYN="N">long covid</Keyword><Keyword MajorTopicYN="N">myopericarditis</Keyword><Keyword MajorTopicYN="N">treatment</Keyword></KeywordList><CoiStatement>The authors have declared that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>11</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>12</Month><Day>16</Day><Hour>6</Hour><Minute>34</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>12</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>12</Month><Day>17</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>11</Month><Day>10</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34912599</ArticleId><ArticleId IdType="pmc">PMC8664614</ArticleId><ArticleId IdType="doi">10.7759/cureus.19449</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Coronavirus disease pandemic (COVID-19)  [
Oct;
2021 
];https://www.who.int/emergencies/diseases/novel-coronavirus-2019 2021 </Citation></Reference><Reference><Citation>Cardiovascular manifestations of COVID-19. Altamimi H, Abid AR, Othman F, Patel A. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7898993/ Heart Views. 2020;21:171&#x2013;186.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7898993</ArticleId><ArticleId IdType="pubmed">33688409</ArticleId></ArticleIdList></Reference><Reference><Citation>The natural history, pathobiology, and clinical manifestations of SARS-CoV-2 infections. Machhi J, Herskovitz J, Senan AM, et al. J Neuroimmune Pharmacol. 2020;15:359&#x2013;386.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7373339</ArticleId><ArticleId IdType="pubmed">32696264</ArticleId></ArticleIdList></Reference><Reference><Citation>Recognizing COVID-19-related myocarditis: the possible pathophysiology and proposed guideline for diagnosis and management. Siripanthong B, Nazarian S, Muser D, et al. Heart Rhythm. 2020;17:1463&#x2013;1471.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7199677</ArticleId><ArticleId IdType="pubmed">32387246</ArticleId></ArticleIdList></Reference><Reference><Citation>Post-acute COVID-19 syndrome and the cardiovascular system: what is known? Dixit NM, Churchill A, Nsair A, Hsu JJ. Am Heart J Plus. 2021;5:100025.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8223036</ArticleId><ArticleId IdType="pubmed">34192289</ArticleId></ArticleIdList></Reference><Reference><Citation>Long COVID-19: challenges in the diagnosis and proposed diagnostic criteria. Raveendran AV. Diabetes Metab Syndr. 2021;15:145&#x2013;146.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7737559</ArticleId><ArticleId IdType="pubmed">33341598</ArticleId></ArticleIdList></Reference><Reference><Citation>A clinical case definition of post COVID-19 condition by a Delphi consensus, 6 October 2021.  [
Oct;
2021 
];A clinical case definition of post COVID-19 condition by a Delphi consensus, 6 October 2021. http://www.who.int/publications/i/item/WHO-2019-nCoV-Post_COVID-19_condition-Clinical_case_definition-2021.1 October 13, 2021. 2021 </Citation></Reference><Reference><Citation>2015 ESC Guidelines for the diagnosis and management of pericardial diseases: the Task Force for the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology (ESC) Adler Y, Charron P, Imazio M, et al. Eur Heart J. 2015;36:2921&#x2013;2964.</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Management of myopericarditis. Imazio M, Cooper LT. Expert Rev Cardiovasc Ther. 2013;11:193&#x2013;201.</Citation><ArticleIdList><ArticleId IdType="pubmed">23405840</ArticleId></ArticleIdList></Reference><Reference><Citation>Acute myopericarditis in the post COVID-19 recovery phase. Rivera-Morales MD, Pell R, Rubero J, Ganti L. Cureus. 2020;12:0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7707144</ArticleId><ArticleId IdType="pubmed">33274129</ArticleId></ArticleIdList></Reference><Reference><Citation>Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Caforio AL, Pankuweit S, Arbustini E, et al. Eur Heart J. 2013;34:2636&#x2013;2648.</Citation><ArticleIdList><ArticleId IdType="pubmed">23824828</ArticleId></ArticleIdList></Reference><Reference><Citation>Pathological evidence for SARS-CoV-2 as a cause of myocarditis: JACC&#xa0;review&#xa0;topic&#xa0;of&#xa0;the&#xa0;week. Kawakami R, Sakamoto A, Kawai K, et al. J Am Coll Cardiol. 2021;77:314&#x2013;325.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7816957</ArticleId><ArticleId IdType="pubmed">33478655</ArticleId></ArticleIdList></Reference><Reference><Citation>Update on myocarditis and inflammatory cardiomyopathy: reemergence of endomyocardial biopsy. Dominguez F, K&#xfc;hl U, Pieske B, Garcia-Pavia P, Tsch&#xf6;pe C. Rev Esp Cardiol (Engl Ed) 2016;69:178&#x2013;187.</Citation><ArticleIdList><ArticleId IdType="pubmed">26795929</ArticleId></ArticleIdList></Reference><Reference><Citation>Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments. Yong SJ. Infect Dis (Lond) 2021;53:737&#x2013;754.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8146298</ArticleId><ArticleId IdType="pubmed">34024217</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>